SCHEMBL5876873

SCHEMBL5876873

Cc1ccc(S(=O)(=O)n2nc(Nc3ccccc3)c3c2CC(c2ccccc2)(c2ccc(F)cc2)C=C3)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
STAT1 P42224 1/20 0.36
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
LMNA P02545 3/20 0.33
MAPT P10636 3/20 0.33
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HTT P42858 1/20 0.33
MAPK14 Q16539 1/20 0.33
KMT2A Q03164 3/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 2/20 0.33
ALDH3A1 P30838 1/20 0.32
PKM P14618 1/20 0.32
TP53 P04637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5877164 0.99 ALDH1A1 (0.37) ALDH1A1STAT1NR1H2NR1H3LMNA
SCHEMBL5875996 0.94 NR1H2 (0.38) ALDH1A1NR1H2NR1H3LMNAMAPT
SCHEMBL5875964 0.92 KMT2A (0.35) ALDH1A1STAT1NR1H2NR1H3LMNA
SCHEMBL5876616 0.91 NR1H2 (0.32) ALDH1A1NR1H2NR1H3LMNAMAPT
SCHEMBL5877371 0.91 KMT2A (0.36) ALDH1A1STAT1NR1H2NR1H3LMNA
SCHEMBL5877764 0.90 NR1H2 (0.35) ALDH1A1NR1H2NR1H3LMNAMAPT
SCHEMBL5875821 0.90 KMT2A (0.40) ALDH1A1STAT1LMNAMAPTKMT2A
SCHEMBL5875901 0.90 MAPT (0.39) ALDH1A1NR1H2NR1H3LMNAMAPT
SCHEMBL5876253 0.89 NR1H2 (0.35) ALDH1A1NR1H2NR1H3LMNAMAPT
SCHEMBL5876533 0.89 KMT2A (0.41) ALDH1A1STAT1LMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119115-B2 Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology AVENTIS PHARMA S.A. (FR) 2006-10-10 US disclosed
US-20040162276-A1 Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology AVENTIS PHARMA S.A. (FR) 2004-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162276-A1 Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology IDO1, IDO2, INMT ALDH1A1 166/4885STAT1 1312/4885NR1H2 556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.